ckd and semaglutide Effects of Once-Weekly on Kidney Disease Outcomes by KDIGO Risk Category in the SUSTAIN 6 Trial Long-term kidney outcomes of semaglutide
Description
However, due to certain side effects like nausea, vomiting, and diarrhea, the risk of dehydration becomes a concern for some patients
Its a GLP-1 receptor agonist, a class of medications that mimic the hormone GLP-1
[DOI] [PubMed] [Google Scholar] 106.Colom F, Vieta E
Retatrutide (Lilly's Triple-G Agonist) Eli Lillys Retatrutide is a triple GIP/GLP-1/glucagon receptor agonist currently in phase 3 trials
Women appear to be more susceptible than men
